Measurement of hemorrhage-related severe maternal morbidity with billing versus electronic medical record data.


Journal

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
ISSN: 1476-4954
Titre abrégé: J Matern Fetal Neonatal Med
Pays: England
ID NLM: 101136916

Informations de publication

Date de publication:
Jun 2022
Historique:
pubmed: 1 7 2020
medline: 29 4 2022
entrez: 30 6 2020
Statut: ppublish

Résumé

Measurement of obstetric hemorrhage-related morbidity is important for quality assurance purposes but presents logistical challenges in large populations. Billing codes are typically used to track severe maternal morbidity but may be of suboptimal validity. The objective of this study was to evaluate the validity of billing code diagnoses for hemorrhage-related morbidity compared to data obtained from the electronic medical record. Deliveries occurring between July 2014 and July 2017 from three hospitals within a single system were analyzed. Three outcomes related to obstetric hemorrhage that are part of the Centers for Disease Control and Prevention definition of severe maternal morbidity (SMM) were evaluated: (i) transfusion, (ii) disseminated intravascular coagulation (DIC), and (iii) acute renal failure (ARF). ICD-9-CM and ICD-10-CM for these conditions were ascertained and compared to blood bank records and laboratory values. Sensitivity, specificity, positive (PPV) and negative predictive values (NPV) with 95% confidence intervals (CI) were calculated. Ancillary analyses were performed comparing codes and outcomes between hospitals and comparing ICD-9-CM to ICD-10-CM codes. Comparisons of categorical variables were performed with the chi-squared test. T-tests were used to compare continuous outcomes. 35,518 deliveries were analyzed. 786 women underwent transfusion, 168 had serum creatinine ≥1.2 mg/dL, and 99, 40, and 16 had fibrinogen ≤200, ≤150, and ≤100 mg/dL, respectively. Transfusion codes were 65% sensitive (95% CI 62-69%) with a 91% PPV (89-94%) for blood bank records of transfusion. DIC codes were 22% sensitive (95% CI 15-32%) for a fibrinogen cutoff of ≤200 mg/dL with 15% PPV (95% CI 10-22%). Sensitivity for ARF was 33% (95% CI 26-41%) for a creatinine of 1.2 mg/dL with a PPV of 63% (95% CI 52-73%). Sensitivity of ICD-9-CM for transfusion was significantly higher than ICD-10-CM (81%, 95% CI 76-86% versus 56%, 95% CI 51-60%, Use of administrative billing codes for postpartum hemorrhage complications may be appropriate for measuring trends related to disease burden and resource utilization, particularly in the case of transfusion, but may be suboptimal for measuring clinical outcomes within and between hospitals.

Identifiants

pubmed: 32594813
doi: 10.1080/14767058.2020.1783229
pmc: PMC7770034
mid: NIHMS1643655
doi:

Substances chimiques

Fibrinogen 9001-32-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2234-2240

Subventions

Organisme : NICHD NIH HHS
ID : K08 HD082287
Pays : United States

Références

Obstet Gynecol. 2017 Aug;130(2):366-373
pubmed: 28697109
Am J Obstet Gynecol. 2008 Nov;199(5):519.e1-7
pubmed: 18639209
J Obstet Gynecol Neonatal Nurs. 2012 Jul-Aug;41(4):551-8
pubmed: 22548283
Semin Perinatol. 2016 Mar;40(2):99-108
pubmed: 26791053
J Intern Med. 2013 Dec;274(6):547-60
pubmed: 23952476
Anesth Analg. 2010 May 1;110(5):1368-73
pubmed: 20237047
Anesth Analg. 2015 Jul;121(1):142-148
pubmed: 26091046
Obstet Gynecol. 2010 Nov;116(5):1018-9
pubmed: 20966682
J Am Med Inform Assoc. 2012 Nov-Dec;19(6):931-8
pubmed: 22683918
Simul Healthc. 2012 Feb;7(1):18-21
pubmed: 22228284
Int J Gynaecol Obstet. 2006 Jun;93(3):220-4
pubmed: 16626718
Obstet Gynecol. 2014 May;123(5):978-981
pubmed: 24785849
Obstet Gynecol. 2012 Nov;120(5):1029-36
pubmed: 23090519

Auteurs

Alexander M Friedman (AM)

Division of Maternal-Fetal Fetal Medicine, Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.

Matthew Oberhardt (M)

New York Presbyterian, Value Institute, New York, NY, USA.

Jean-Ju Sheen (JJ)

Division of Maternal-Fetal Fetal Medicine, Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.

Alan Kessler (A)

Department of Obstetrics and Gynecology, Weill-Cornell Medical Center, New York, NY, USA.

David Vawdrey (D)

New York Presbyterian, Value Institute, New York, NY, USA.

Robert Green (R)

New York Presbyterian, Value Institute, New York, NY, USA.

Mary E D'Alton (ME)

Division of Maternal-Fetal Fetal Medicine, Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.

Dena Goffman (D)

Division of Maternal-Fetal Fetal Medicine, Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.
New York Presbyterian, Value Institute, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH